More on psilocybin
Current Psychiatry – February 01, 2023
Source: OpenAlex
Summary
Oregon has legalized psilocybin for therapeutic use, signaling a profound shift in Psychiatry and Medicine. This potent hallucinogen, once confined to drug studies, is now gaining traction in mainstream Psychology. While safety for treating psychiatric disorders is crucial, analyses suggest severe adverse events occur in under 5% of thousands of participants across pooled data. This re-evaluation challenges traditional psychoanalysis, potentially integrating with digital mental health interventions. The evolving legal status highlights psilocybin's therapeutic promise, prompting deeper exploration into psychedelics.
Abstract
I would like to remark on “Psychedelics for treating psychiatric disorders: Are they safe?” (Current Psychiatry, December 2022, p. 14-22, doi:10.12788/ cp.0309), specifically “psilocybin use has been decriminalized … and some states (such as Oregon) have legalized it for therapeutic use.